BMC Musculoskeletal Disorders

official impact factor 1.94

Open Access Highly Access Research article

S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]

Wadie I Najm*, Sibylle Reinsch, Fred Hoehler, Jerome S Tobis and Phillip W Harvey

BMC Musculoskeletal Disorders 2004, 5:6 doi:10.1186/1471-2474-5-6

No comments have yet been made on this article.

Post a comment